Events2Join

DEA and HHS Extend Telemedicine Flexibilities through 2024


DEA and HHS Extend Telemedicine Flexibilities through 2024

DEA, jointly with the Department of Health and Human Services (HHS), has extended current telemedicine flexibilities through December 31, 2024.

DEA to Extend Telemedicine Prescription Flexibilities?

IN DEPTH · The current telemedicine flexibilities are set to expire December 31, 2024, without further action by the DEA or Congress. · After ...

AHA urges DEA and HHS to extend waivers of in-person ...

The AHA Oct. 4 urged the Drug Enforcement Administration and Department of Health and Human Services to extend telehealth flexibilities an ...

Prescribing controlled substances via telehealth

The Drug Enforcement Administration (DEA), jointly with the Department of Health ... health emergency (PHE), through December 31, 2024.

Second Temporary Extension of COVID-19 Telemedicine ...

Paragraph (c) is amended to extend the COVID-19 telemedicine prescribing flexibilities from May 12, 2023 through December 31, 2024, provided all ...

New DEA Rule Expected to Extend Controlled Substance ...

In late August 2024, POLITICO broke news on the DEA's internal plans to release an unworkable regulation that would render telemedicine ...

DEA to Extend Telemedicine Prescription Flexibilities?

In Depth · The current telemedicine flexibilities are set to expire December 31, 2024, without further action by the DEA or Congress. · After ...

Telehealth prescribing flexibilities may be extended by 1 year

DEA sends 3rd temporary extension of telemedicine prescribing rules to White House ... The Drug Enforcement Administration is poised to extend ...

AHA Requests Flexibility Extension from HHS on DEA Telemedicine ...

The DEA in coordination with HHS extended existing waivers through 2024 to permit adequate time to review and address comments. As such ...

DEA and SAMHSA Extend Telemedicine Flexibilities Again

The Second Temporary Rule will extend exceptions to existing DEA regulations for all practitioner-patient relationships through December 31, 2024.

DEA Expected to Extend Telehealth Flexibilities for Controlled ...

DEA received more than 38,000 public comments following its proposed rule in February 2023 for telemedicine prescribing of controlled substances ...

DEA, HHS Extend Telemedicine Flexibilities Through 2024

These telemedicine flexibilities authorize qualified health professionals to prescribe to patients Schedule II-V controlled medications via audio-video ...

DEA Prepares to Issue Rule on Telehealth Prescribing

According to the anonymous source, the draft telemedicine prescribing rule, expected to be out in September, limits the types of medications ...

Exceptions for Telehealth Prescribing Extended Until End of 2024

Background: In March, in anticipation of the May 2023 end of the Public Health Emergency, DEA and HHS issued a proposed rule on prescribing controlled ...

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for ...

For any practitioner-patient telemedicine relationships that have been or will be established up to November 11, 2023, the full set of ...

DEA and HHS Extend Telemedicine Flexibilities for Controlled ...

The DEA and HHS have clarified their intention to promulgate final telemedicine prescription rules by Fall 2024. The long rulemaking period, ...

DEA and HHS Extend Telehealth Prescribing Flexibilities Again

The DEA and DHHS issued the first temporary extension on May 10, 2023, allowing providers to prescribe controlled substances through telehealth to new patients.

As year-end deadline looms, Congress again calls on DEA to ...

With time running short, a third extension on telehealth prescribing flexibilities is needed to allow for a public comment period on the DEA's ...

DEA Issues Second Temporary Extension of COVID-19 ...

DEA Issues Second Temporary Extension of COVID-19 Telemedicine Prescribing Flexibilities, Through 2024 ... The Second Temporary Rule is scheduled ...

DEA again extends telemedicine flexibilities - CNN

Now, after holding two days of public listening sessions on the rules in September, the DEA and HHS have further extended the flexibilities ...